Digital nutritional therapy in patients with type 2 diabetes: a real-world outcome analysis

被引:0
|
作者
Sutter, A. [1 ]
Jones, L. [1 ]
Ghosh, A. [1 ]
Schenk, M. [1 ]
机构
[1] Oviva AG, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
780
引用
收藏
页码:S377 / S377
页数:1
相关论文
共 50 条
  • [31] Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
    Davies, M. J.
    Gagliardino, J. J.
    Gray, L. J.
    Khunti, K.
    Mohan, V.
    Hughes, R.
    DIABETIC MEDICINE, 2013, 30 (05) : 512 - 524
  • [32] Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data
    Krishnakumar, Arjun
    Verma, Ritika
    Chawla, Rajeev
    Sosale, Aravind
    Saboo, Banshi
    Joshi, Shilpa
    Shaikh, Maaz
    Shah, Abhishek
    Kolwankar, Siddhesh
    Mattoo, Vinod
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (03)
  • [33] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [34] Correction to "Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus"
    Kelly, M. S.
    Scopelliti, E. M.
    Goodson, K. E.
    Lo, C. M. A.
    Nguyen, H. X.
    Simon, B.
    DIABETES OBESITY & METABOLISM, 2024,
  • [35] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [36] Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes
    Walraven, Iris
    Mast, M. Ruth
    Hoekstra, Trynke
    Jansen, Aaltje P. D.
    Rauh, Simone P.
    Rutters, Femke R.
    van der Heijden, Amber A. W. A.
    Elders, Petra J. M.
    Moll, Annette C.
    Polak, Bettine C. P.
    Dekker, Jacqueline M.
    Nijpels, Giel
    JOURNAL OF HYPERTENSION, 2015, 33 (10) : 2091 - 2098
  • [37] A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
    Blonde, Lawrence
    Patel, Charmi
    Bookhart, Brahim
    Pfeifer, Michael
    Chen, Yen-Wen
    Wu, Bingcao
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1143 - 1152
  • [38] Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
    Gabler, Maximilian
    Picker, Nils
    Geier, Silke
    Foersch, Johannes
    Aberle, Jens
    Martin, Stephan
    Riedl, Matthias
    Wilke, Thomas
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
  • [39] The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients
    Crivera, C.
    Suh, D. C.
    Huang, E. S.
    Cagliero, E.
    Grant, R. W.
    Vo, L.
    Shin, H. C.
    Meigs, J. B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2301 - 2311
  • [40] Type 1 diabetes: analysis of real-world insulin injection patterns
    Catrina, S.
    Hartvig, N.
    Kaas, A.
    Moller, J.
    Mardby, A. -C.
    Jendle, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S378 - S378